Perspective Therapeutics (CATX) Shares Issued (2010 - 2026)

Perspective Therapeutics has disclosed Shares Issued across 16 years of filings, most recently posting $290000.0 for Q1 2026.

• Shares Issued for Q1 2026 came in at $290000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $290000.0 (down 74.27% YoY), and the FY2024 annual result was $1.3 million, changed N/A from the prior year.
• Shares Issued came in at $290000.0 for Q1 2026 at Perspective Therapeutics, up from -$371000.0 in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $642000.0 in Q3 2024 to a low of -$56.3 million in Q2 2022.
• The 5-year median for Shares Issued is $128000.0 (2024), against an average of -$4.2 million.
• Across the five-year window, Shares Issued soared 1233.33% in 2023 and plunged 203.92% in 2025, its largest moves.
• Perspective Therapeutics' Shares Issued stood at $30000.0 in 2022, then jumped by 1233.33% to $400000.0 in 2023, then retreated by 10.75% to $357000.0 in 2024, then slumped by 203.92% to -$371000.0 in 2025, then soared by 178.17% to $290000.0 in 2026.
• The last three Shares Issued figures came in at $290000.0 (Q1 2026), -$371000.0 (Q4 2025), and $226000.0 (Q3 2025), per Business Quant data.